Literature DB >> 23277554

Convergent and divergent effects of costimulatory molecules in conventional and regulatory CD4+ T cells.

Ei Wakamatsu1, Diane Mathis, Christophe Benoist.   

Abstract

Costimulatory molecules of the CD28 family on T lymphocytes integrate cues from innate immune system sensors and modulate activation responses in conventional CD4(+) T cells (Tconv) and their FoxP3(+) regulatory counterparts (Treg). To better understand how costimulatory and coinhibitory signals might be integrated, we profiled the changes in gene expression elicited in the hours and days after engagement of Treg and Tconv by anti-CD3 and either anti-CD28, -CTLA4, -ICOS, -PD1, -BLA, or -CD80. In Tconv, a shared "main response" was induced by CD28, ICOS, and, surprisingly, BTLA and CD80, with very limited CD28-specific (primarily Il2) or ICOS-specific elements (including Th1 and Th2 but not the follicular T signature). CTLA4 and PD1 had a very subtle impact in this system, similarly inhibiting the response to anti-CD3. Treg responded to the same costimulatory hierarchy and to the same extent as Tconv, but inducing different clusters of genes. In this reductionist system, costimulatory or coinhibitory engagement mainly elicits generic responses, suggesting that the variability of their effects in vivo result from temporal or anatomical differences in their engagement, rather than from inherently different wiring.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23277554      PMCID: PMC3549117          DOI: 10.1073/pnas.1220688110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

2.  Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells.

Authors:  Somia P Hickman; Jaeseok Yang; Rajan M Thomas; Andrew D Wells; Laurence A Turka
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

3.  Altered proximal T cell receptor (TCR) signaling in human CD4+CD25+ regulatory T cells.

Authors:  Julia Yuen-Shan Tsang; Niels Olsen Saraiva Camara; Efrem Eren; Helga Schneider; Christopher Rudd; Giovanna Lombardi; Robert Lechler
Journal:  J Leukoc Biol       Date:  2006-05-09       Impact factor: 4.962

4.  Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA.

Authors:  Maya Gavrieli; Kenneth M Murphy
Journal:  Biochem Biophys Res Commun       Date:  2006-05-15       Impact factor: 3.575

5.  CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

Authors:  C B Thompson; T Lindsten; J A Ledbetter; S L Kunkel; H A Young; S G Emerson; J M Leiden; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

6.  CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.

Authors:  Richard V Parry; Jens M Chemnitz; Kenneth A Frauwirth; Anthony R Lanfranco; Inbal Braunstein; Sumire V Kobayashi; Peter S Linsley; Craig B Thompson; James L Riley
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

7.  Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling.

Authors:  F Pagès; M Ragueneau; R Rottapel; A Truneh; J Nunes; J Imbert; D Olive
Journal:  Nature       Date:  1994-05-26       Impact factor: 49.962

8.  Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation.

Authors:  Michelle A Hurchla; John R Sedy; Kenneth M Murphy
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

9.  Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.

Authors:  Manish J Butte; Mary E Keir; Theresa B Phamduy; Arlene H Sharpe; Gordon J Freeman
Journal:  Immunity       Date:  2007-07-12       Impact factor: 31.745

10.  Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors.

Authors:  James L Riley; Mao Mao; Sumire Kobayashi; Matt Biery; Julja Burchard; Guy Cavet; Brian P Gregson; Carl H June; Peter S Linsley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

View more
  39 in total

1.  Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter.

Authors:  Krit Ritthipichai; Cara L Haymaker; Melisa Martinez; Andrew Aschenbrenner; Xiaohui Yi; Minying Zhang; Charuta Kale; Luis M Vence; Jason Roszik; Yared Hailemichael; Willem W Overwijk; Navin Varadarajan; Roza Nurieva; Laszlo G Radvanyi; Patrick Hwu; Chantale Bernatchez
Journal:  Clin Cancer Res       Date:  2017-07-28       Impact factor: 12.531

Review 2.  Signals that drive T follicular helper cell formation.

Authors:  Louise M C Webb; Michelle A Linterman
Journal:  Immunology       Date:  2017-07-17       Impact factor: 7.397

3.  Imbalanced signal transduction in regulatory T cells expressing the transcription factor FoxP3.

Authors:  Dapeng Yan; Julia Farache; Michael Mingueneau; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

4.  The X-linked intellectual disability protein PHF6 associates with the PAF1 complex and regulates neuronal migration in the mammalian brain.

Authors:  Chi Zhang; Luis A Mejia; Ju Huang; Pamela Valnegri; Eric J Bennett; Julius Anckar; Arezu Jahani-Asl; Gilbert Gallardo; Yoshiho Ikeuchi; Tomoko Yamada; Michael Rudnicki; J Wade Harper; Azad Bonni
Journal:  Neuron       Date:  2013-06-19       Impact factor: 17.173

Review 5.  Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma.

Authors:  Liliana E Lucca; David A Hafler
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

6.  Conservation and divergence in the transcriptional programs of the human and mouse immune systems.

Authors:  Tal Shay; Vladimir Jojic; Or Zuk; Katherine Rothamel; David Puyraimond-Zemmour; Ting Feng; Ei Wakamatsu; Christophe Benoist; Daphne Koller; Aviv Regev
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 7.  Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy.

Authors:  Anne M Macpherson; Simon C Barry; Carmela Ricciardelli; Martin K Oehler
Journal:  J Clin Med       Date:  2020-09-14       Impact factor: 4.241

8.  Protein Prenylation Drives Discrete Signaling Programs for the Differentiation and Maintenance of Effector Treg Cells.

Authors:  Wei Su; Nicole M Chapman; Jun Wei; Hu Zeng; Yogesh Dhungana; Hao Shi; Jordy Saravia; Peipei Zhou; Lingyun Long; Sherri Rankin; Anil Kc; Peter Vogel; Hongbo Chi
Journal:  Cell Metab       Date:  2020-11-17       Impact factor: 27.287

9.  Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance.

Authors:  Simon Glatigny; Barbara Höllbacher; Samantha J Motley; Cathy Tan; Christian Hundhausen; Jane H Buckner; Dawn Smilek; Samia J Khoury; Linna Ding; Tielin Qin; Jorge Pardo; Gerald T Nepom; Laurence A Turka; Kristina M Harris; Daniel J Campbell; Estelle Bettelli
Journal:  J Immunol       Date:  2019-01-25       Impact factor: 5.422

10.  Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells.

Authors:  Sascha Kahlfuß; Narasimhulu Simma; Judith Mankiewicz; Tanima Bose; Theresa Lowinus; Stefan Klein-Hessling; Rolf Sprengel; Burkhart Schraven; Martin Heine; Ursula Bommhardt
Journal:  Mol Cell Biol       Date:  2013-12-16       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.